EDAP TMS reported EUR18.8M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AngioDynamics USD 81.95M 1.68M Sep/2025
Boston Scientific USD 4.15B 107M Mar/2026
EDAP TMS EUR 18.8M 3.01M Sep/2025
Henry Schein USD 3.17B 77M Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Veracyte USD 119.99M 3.99M Mar/2026